表紙
市場調查報告書

美國:切片檢查市場 & 數量分析

United States Biopsy Market, Volume & Forecast by Segments (Breast, Prostate, Lung, Liver ,Thyroid, Kidney, Colorectal and Skin) Cancer, Companies

出版商 Renub Research 商品編碼 349637
出版日期 內容資訊 英文 113 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國:切片檢查市場 & 數量分析 United States Biopsy Market, Volume & Forecast by Segments (Breast, Prostate, Lung, Liver ,Thyroid, Kidney, Colorectal and Skin) Cancer, Companies
出版日期: 2019年10月01日內容資訊: 英文 113 Pages
簡介

本報告提供美國的切片檢查市場相關的總括性調查,癌症的5大市場區隔的市場分析與數量的預測,切片檢查市場促進要素與課題分析等相關彙整。

第1章 摘要整理

第2章 美國的切片檢查市場:數量、預測

  • 市場 & 預測
  • 數量 & 預測

第3章 美國的切片檢查市場 & 數量佔有率分析

  • 市場佔有率 & 預測
  • 數量佔有率 & 預測

第4章 美國的切片檢查市場 & 數量預測:檢驗市場區隔分析

  • 前列腺癌
  • 乳癌
  • 肺癌
  • 肝癌
  • 甲狀腺癌

第5章 美國的切片檢查市場:促進成長要素

第6章 美國的切片檢查市場:課題

第7章 企業分析

  • C. R. Bard, Inc.
  • Becton, Dickinson and Company
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Olympus Corporation
  • Boston Scientific Corporation
  • Medtronic plc
  • Hologic, Inc.

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The biopsy is the procedure to collect the tissues or fluid from the area, which has grown abnormally over a period of time. The sample (tissue or fluid) is further examined through the microscope to check the presence of cancer. Different types of biopsy are done to know cancer, such as vacuum-assisted biopsy, fine-needle aspiration biopsy, and core needle biopsy. For colorectal cancer, colonoscopy or endoscopy is primarily done to check abnormalities, and during the process, abnormal tissues called polyps would collect for biopsy. In the United States, overall cancer incidence is rising, but the cancer death rate is falling over the period of time because of the rise in the number of cancer diagnostics, especially biopsy screening for cancer. United States Biopsy Market is expected to cross US$ 14 Billion mark by the end of the year 2025.

The essential factors that will fuel the market growth are; the rise of an ageing population in the United States, continuous improvement of healthcare infrastructure, rising per capita health care expenditure, increasing per capita income, growing awareness about early detection of cancer by several screening including biopsy, improvement of diagnostic technologies, etc. Moreover, the rising incidence of cancer in the United States and increase of less invasive procedures during biopsy will further propel the United States biopsy market in the future course of time.

Renub Research report titled "United States Biopsy Market, Volume & Forecast by Segments (Breast, Prostate, Lung, Liver ,Thyroid, Kidney, Colorectal and Skin) Cancer, Companies (C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, FUJIFILM Holdings Corporation, Medtronic plc., Hologic, Inc)" provides a complete analysis of the United States Biopsy Market and Volume.

United States Biopsy Volume Insights - Breast Cancer Biopsy is holding the largest Volume Share

In this report, we have fragmented cancer by biopsy volume into 8 parts; Breast Cancer, Prostate Cancer, Lung Cancer, Liver Cancer, Thyroid Cancer, Kidney Cancer, Colorectal Cancer, and Skin Cancer. Breast cancer biopsy is holding the largest volume share of cancer biopsy in the United States. This report provides a multifactor analysis of why biopsy volume is rising in the United States.

United States Biopsy Market Insights

In this report, we have categorized the biopsy market into 8 parts by cancer type; Breast Cancer, Prostate Cancer, Lung Cancer, Liver Cancer, Thyroid Cancer, Kidney Cancer, Colorectal Cancer, and Skin Cancer. For many cancer, more than one biopsy is required to diagnose the patients like colorectal cancer requires at least 6 biopsies. Besides, we have also explained the growth driver and challenges of the biopsy market in the United States.

United States New Cases of Cancer Diagnostic Insights

In this report, we have shown new cancer diagnostic cases and also providing the factor by which cancer prevalence is increasing or decreasing over a period of time.

Segments Covered in the Report:

  • Breast Cancer Biopsy
  • Prostate Cancer Biopsy
  • Lung Cancer Biopsy
  • Liver Cancer Biopsy
  • Thyroid Cancer Biopsy
  • Kidney Cancer Biopsy
  • Colorectal Cancer Biopsy
  • Skin Cancer Biopsy

Key Companies Covered in the Report:

  • C. R. Bard, Inc.
  • Becton, Dickinson and Company
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Olympus Corporation
  • FUJIFILM Holdings Corporation
  • Medtronic plc.
  • Hologic, Inc

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. United States Biopsy Market & Volume

  • 4.1 Market & Forecast
  • 4.2 Volume & Forecast

5. United States Biopsy Share

  • 5.1 Market Share & Forecast
  • 5.2 Volume Share & Forecast

6. Segment - United States Biopsy Market

  • 6.1 Prostate Cancer Biopsy
    • 6.1.1 Market & Forecast
    • 6.1.2 Volume & Forecast
  • 6.2 Breast Cancer Biopsy
    • 6.2.1 Market & Forecast
    • 6.2.2 Volume & Forecast
  • 6.3 Lung Cancer Biopsy
    • 6.3.1 Market & Forecast
    • 6.3.2 Volume & Forecast
  • 6.4 Liver Cancer Biopsy
    • 6.4.1 Market & Forecast
    • 6.4.2 Volume & Forecast
  • 6.5 Thyroid Cancer Biopsy
    • 6.5.1 Market & Forecast
    • 6.5.2 Volume & Forecast
  • 6.6 Kidney Cancer Biopsy
    • 6.6.1 Market & Forecast
    • 6.6.2 Volume & Forecast
  • 6.7 Colon & Rectum Cancer Biopsy
    • 6.7.1 Market & Forecast
    • 6.7.2 Volume & Forecast
  • 6.8 Melanoma Skin Cancer Biopsy
    • 6.8.1 Market & Forecast
    • 6.8.2 Volume & Forecast

7. Company Analysis

  • 7.1 Becton, Dickinson & Company
    • 7.1.1 Overview
    • 7.1.2 Initiatives & Recent Developments
    • 7.1.3 Mergers & Acquisitions
    • 7.1.4 Revenue
  • 7.2 B. Braun Melsungen AG (Germany)
    • 7.2.1 Overview
    • 7.2.2 Initiatives & Recent Developments
    • 7.2.3 Mergers & Acquisitions
    • 7.2.4 Revenue
  • 7.3 Cardinal Health, Inc.
    • 7.3.1 Overview
    • 7.3.2 Initiatives & Recent Developments
    • 7.3.3 Mergers & Acquisitions
    • 7.3.4 Revenue
  • 7.4 Olympus Corporation (Japan)
    • 7.4.1 Overview
    • 7.4.2 Initiatives & Recent Developments
    • 7.4.3 Mergers & Acquisitions
    • 7.4.4 Revenue
  • 7.5 Boston Scientific Corporation (U.S.)
    • 7.5.1 Overview
    • 7.5.2 Initiatives & Recent Developments
    • 7.5.3 Mergers & Acquisitions
    • 7.5.4 Revenue
  • 7.6 Medtronic Plc.
    • 7.6.1 Overview
    • 7.6.2 Initiatives & Recent Developments
    • 7.6.3 Mergers & Acquisitions
    • 7.6.4 Revenue
  • 7.7 Hologic, Inc.
    • 7.7.1 Overview
    • 7.7.2 Initiatives & Recent Developments
    • 7.7.3 Mergers & Acquisitions
    • 7.7.4 Revenue

8. Growth Factors

  • 8.1 Inadequate Screening Tests for Particular Cancers
  • 8.2 Demand for Minimally-Invasive Biopsy Techniques
  • 8.3 Advancement in Biopsy Techniques

9. Challenges

  • 9.1 Reimbursement Issues
  • 9.2 Limitations

List of Figures:

  • Figure-01: United States - Biopsy Market (Million US$), 2010 - 2018
  • Figure-02: United States - Forecast for Biopsy Market (Million US$), 2019 - 2025
  • Figure-03: United States - Biopsy Volume (Thousands), 2010 - 2018
  • Figure-04: United States - Forecast for Biopsy Volume (Thousands), 2019 - 2025
  • Figure-05: United States - Biopsy Market Share (%), 2010 - 2018
  • Figure-06: United States - Forecast for Biopsy Market Share (%), 2019 - 2025
  • Figure-07: United States - Biopsy Volume Share (%), 2010 - 2018
  • Figure-08: United States - Forecast for Biopsy Volume Share (%), 2019 - 2025
  • Figure-09: United States - Prostate Cancer Biopsy Market (Million US$), 2010 - 2018
  • Figure-10: United States - Forecast for Prostate Cancer Biopsy Market (Million US$), 2019 - 2025
  • Figure-11: United States - Prostate Cancer Biopsy Volume (Thousands), 2010 - 2018
  • Figure-12: United States - Forecast for Prostate Cancer Biopsy Volume (Thousands), 2019 - 2025
  • Figure-13: United States - Breast Cancer Biopsy Market (Million US$), 2010 - 2018
  • Figure-14: United States - Forecast for Breast Cancer Biopsy Market (Million US$), 2019 - 2025
  • Figure-15: United States - Breast Cancer Biopsy Volume (Thousands), 2010 - 2018
  • Figure-16: United States - Forecast for Breast Cancer Biopsy Volume (Thousands), 2019 - 2025
  • Figure-17: United States - Lung Cancer Biopsy Market (Million US$), 2010 - 2018
  • Figure-18: United States - Forecast for Lung Cancer Biopsy Market (Million US$), 2019 - 2025
  • Figure-19: United States - Lung Cancer Biopsy Volume (Thousands), 2010 - 2018
  • Figure-20: United States - Forecast for Lung Cancer Biopsy Volume (Thousands), 2019 - 2025
  • Figure-21: United States - Liver Cancer Biopsy Market (Million US$), 2010 - 2018
  • Figure-22: United States - Forecast for Liver Cancer Biopsy Market (Million US$), 2019 - 2025
  • Figure-23: United States - Liver Cancer Biopsy Volume (Thousands), 2010 - 2018
  • Figure-24: United States - Forecast for Liver Cancer Biopsy Volume (Thousands), 2019 - 2025
  • Figure-25: United States - Thyroid Cancer Biopsy Market (Million US$), 2010 - 2018
  • Figure-26: United States - Forecast for Thyroid Cancer Biopsy Market (Million US$), 2019 - 2025
  • Figure-27: United States - Thyroid Cancer Biopsy Volume (Thousands), 2010 - 2018
  • Figure-28: United States - Forecast for Thyroid Cancer Biopsy Volume (Thousands), 2019 - 2025
  • Figure-29: United States - Kidney Cancer Biopsy Market (Million US$), 2010 - 2018
  • Figure-30: United States - Forecast for Kidney Cancer Biopsy Market (Million US$), 2019 - 2025
  • Figure-31: United States - Kidney Cancer Biopsy Volume (Thousands), 2010 - 2018
  • Figure-32: United States - Forecast for Kidney Cancer Biopsy Volume (Thousands), 2019 - 2025
  • Figure-33: United States - Colon & Rectum Cancer Biopsy Market (Million US$), 2010 - 2018
  • Figure-34: United States - Forecast for Colon & Rectum Cancer Biopsy Market (Million US$), 2019 - 2025
  • Figure-35: United States - Colon & Rectum Cancer Biopsy Volume (Thousands), 2010 - 2018
  • Figure-36: United States - Forecast for Colon & Rectum Cancer Biopsy Volume (Thousands), 2019 - 2025
  • Figure-37: United States - Melanoma Skin Cancer Biopsy Market (Million US$), 2010 - 2018
  • Figure-38: United States - Forecast for Melanoma Skin Cancer Biopsy Market (Million US$), 2019 - 2025
  • Figure-39: United States - Melanoma Skin Cancer Biopsy Volume (Thousands), 2010 - 2018
  • Figure-40: United States - Forecast for Melanoma Skin Cancer Biopsy Volume (Thousands), 2019 - 2025
  • Figure-41: Becton, Dickinson and Company - Revenue (Million US$), 2010 - 2018
  • Figure-42: Becton, Dickinson and Company - Forecasted Revenue (Million US$), 2019 - 2025
  • Figure-43: B. Braun Melsungen AG - Revenue (Million US$), 2011 - 2018
  • Figure-44: B. Braun Melsungen AG - Forecasted Revenue (Million US$), 2019 - 2025
  • Figure-45: Cardinal Health, Inc. - Revenue (Billion US$), 2010 - 2018
  • Figure-46: Cardinal Health, Inc. - Forecasted Revenue (Billion US$), 2019 - 2025
  • Figure-47: Olympus Corporation - Revenue (Million US$), 2010 - 2018
  • Figure-48: Olympus Corporation - Forecasted Revenue (Million US$), 2019 - 2025
  • Figure-49: Boston Scientific Corporation - Revenue (Million US$), 2010 - 2018
  • Figure-50: Boston Scientific Corporation - Forecasted Revenue (Million US$), 2019 - 2025
  • Figure-51: Medtronic Plc. - Revenue (Million US$), 2010 - 2018
  • Figure-52: Medtronic Plc. - Forecasted Revenue (Million US$), 2019 - 2025
  • Figure-53: Hologic, Inc. - Revenue (Million US$), 2013 - 2018
  • Figure-54: Hologic, Inc. - Forecasted Revenue (Million US$), 2019 - 2025

List of Tables:

  • Table 6-1: New Bundled Codes for Breast Biopsy With Image Guidance
  • Table 6-2: Breast Biopsy - Final Medicare Physician Fee Schedule, 2015
Back to Top